A study shows that ALK and ROS1 gene rearrangements known to drive subsets of lung cancer are also present in some colorectal cancers. These results imply that drugs used to target ALK and ROS1 in lung cancer may also have applications in this subset of colorectal cancer patients.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/D...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/D...



Tendencias Científicas
La prevención del VIH no llega a las jóvenes sudafricanas

CIENCIA ON LINE